Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Active, not recruiting	Phase 2	2025-12-24		NCT05130827

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BeyondSpring Pharmaceuticals Inc.	3
Memorial Sloan Kettering Cancer Center	753

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)	Basking Ridge	United States	131
Memorial Sloan Kettering Bergen (Limited Protocol Activities)	Montvale	United States	184
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities)	Commack	United States	14
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)	Middletown	United States	186
Memorial Sloan Kettering Nassau (Limited Protocol Activities)	Rockville Centre	United States	35
Memorial Sloan Kettering Westchester (Limited Protocol Activities)	Harrison	United States	166